Advertisement

A Patient Presented with Extensive Lung Metastases of Papillary Thyroid Carcinoma Without Any Primary Focus Detected on Total Thyroidectomy

  • Tevfik Fikret Çermik
  • Nurhan Ergül
Chapter

Abstract

The most common metastatic sites of differentiated thyroid cancer (DTC) are the lung and bone after lymph nodes. A newly defined type of occult DTC is consistent with metastatic disease without an identified primary malignancy in the thyroid gland after total resection. We present a patient with multiple lung metastases of occult DTC showing mild 18F-fluorodeoxyglucose (FDG) uptake and intense radioiodine uptake without a primary lesion in the thyroid gland.

Keywords

Occult differentiated thyroid cancer Lung metastasis FDG PET/CT Radioiodine 

References

  1. 1.
    Sampson E, Brierley JD, Le LW, Rotstein L, Tsang RW. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer. 2007;110:1451–6.CrossRefGoogle Scholar
  2. 2.
    Kalra R, Pawar R, Hasija S, Chandna A, Sankla M, Malhotra C. Frontal bone metastasis from an occult follicular thyroid carcinoma: diagnosed by FNAC. J Cytol. 2017;34:59–61.CrossRefGoogle Scholar
  3. 3.
    Liu H, Lv L, Yang K. Occult thyroid carcinoma: a rare case report and review of literature. Int J Clin Exp Pathol. 2014;7:5210–4.PubMedPubMedCentralGoogle Scholar
  4. 4.
    Borsò E, Boni G, Mazzarri S, Cocciaro A, Gambacciani C, Traino AC, et al. Disseminated bone metastases from occult thyroid cancer effectively treated with debulking surgery and a single dosimetry-guided administration of radioiodine. Rev Esp Med Nucl Imagen Mol. 2015;34:111–5.PubMedGoogle Scholar
  5. 5.
    Xu B, Scognamiglio T, Cohen PR, Prasad ML, Hasanovic A, Michael Tuttle R, et al. Metastatic thyroid carcinoma without identifiable primary tumor within the thyroid gland: a retrospective study of a rare phenomenon. Hum Pathol. 2017;65:133–9.CrossRefGoogle Scholar
  6. 6.
    Kaseda K, Watanabe K, Sakamaki H, Kazama A. Solitary pulmonary metastasis from occult papillary thyroid carcinoma. Thorac Cancer. 2016;7:261–3.CrossRefGoogle Scholar
  7. 7.
    Qutbi M, Shafeie B, Amoui M, Tabeie F, Azizmohammadi Z, Mahmoud-Pashazadeh A, et al. Evaluation of prognostic factors associated with differentiated thyroid carcinoma with pulmonary metastasis. Clin Nucl Med. 2016;41:917–21.CrossRefGoogle Scholar
  8. 8.
    Kim M, Kim WG, Park S, Kwon H, Jeon MJ, Lee JJ, et al. Initial size of metastatic lesions is best prognostic factor in patients with metastatic differentiated thyroid carcinoma confined to the lung. Thyroid. 2017;27:49–58.CrossRefGoogle Scholar
  9. 9.
    Song HJ, Qiu ZL, Shen CT, Wei WJ, Luo QY. Pulmonary metastases in differentiated thyroid cancer: efficacy of radioiodine therapy and prognostic factors. Eur J Endocrinol. 2015;173:399–408.CrossRefGoogle Scholar
  10. 10.
    Wang R, Zhang Y, Tan J, Zhang G, Zhang R, Zheng W, et al. Analysis of radioiodine therapy and prognostic factors of differentiated thyroid cancer patients with pulmonary metastasis: an 8-year retrospective study. Medicine (Baltimore). 2017;96:e6809.  https://doi.org/10.1097/MD.0000000000006809.CrossRefGoogle Scholar
  11. 11.
    Biko J, Reiners C, Kreissl MC, Verburg FA, Demidchik Y, Drozd V. Favourable course of disease after incomplete remission on (131)I therapy in children with pulmonary metastases of papillary thyroid carcinoma: 10 years follow-up. Eur J Nucl Med Mol Imaging. 2011;38:651–5.CrossRefGoogle Scholar
  12. 12.
    Basu S, Parghane RV. Designing and developing PET-based precision model in thyroid carcinoma: the potential avenues for a personalized clinical care. PET Clin. 2017;12:27–37.CrossRefGoogle Scholar
  13. 13.
    Giraudet AL, Taïeb D. PET imaging for thyroid cancers: current status and future directions. Ann Endocrinol. 2017;78:38–42.CrossRefGoogle Scholar
  14. 14.
    Vrachimis A, Burg MC, Wenning C, Allkemper T, Weckesser M, Schäfers M. [(18)F]FDG PET/CT outperforms [(18)F]FDG PET/MRI in differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2016;43:212–20.CrossRefGoogle Scholar
  15. 15.
    Kim MS, Sim YS, Lee SY, Jeon DG. Occult thyroid carcinoma detected by FDG-PET scan in elderly osteosarcoma patients: report of two cases. Ann Nucl Med. 2007;21:529–32.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  • Tevfik Fikret Çermik
    • 1
  • Nurhan Ergül
    • 1
  1. 1.University of Health Sciences, İstanbul Training and Research Hospital, Clinic of Nuclear MedicineIstanbulTurkey

Personalised recommendations